<?xml version="1.0" encoding="UTF-8"?>
<ref id="B109-pharmaceutics-13-00327">
 <label>109.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Sartori</surname>
    <given-names>S.B.</given-names>
   </name>
   <name>
    <surname>Singewald</surname>
    <given-names>N.</given-names>
   </name>
  </person-group>
  <article-title>Novel pharmacological targets in drug development for the treatment of anxiety and anxiety-related disorders</article-title>
  <source>Pharmacol. Ther.</source>
  <year>2019</year>
  <volume>204</volume>
  <elocation-id>107402</elocation-id>
  <pub-id pub-id-type="doi">10.1016/j.pharmthera.2019.107402</pub-id>
  <pub-id pub-id-type="pmid">31470029</pub-id>
 </element-citation>
</ref>
